Agreement centers on identifying HER2 gene mutations using Oncomine Dx Target Test CARLSBAD, Calif. — Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo Fisher’s next-generation sequencing (NGS)-based Oncomine Dx Target Test. The CDx will be designed to identify non-small cell lung cancer (NSCLC) […]
DURHAM, N.C. — BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it has entered into an exclusive worldwide licensing agreement with St. Jude Children’s Research Hospital, the nation’s leading hospital dedicated to understanding, treating and curing childhood cancer and other life-threatening diseases. BioSkryb will […]
Funding by CVC Credit Partners will support the business’s buy-and-build growth strategy CVC Credit Partners (“CVC Credit”) is pleased to announce that it has provided a $92 million multicurrency first lien credit facility to Calibre Scientific, the life sciences and diagnostics business owned by StoneCalibre. Funding provided by CVC Credit will be used to refinance […]
New solutions for studying RNA for infectious disease, oncology, and genetic disease research We are excited for the launch of the expanded RNA Library Preparation product portfolio. The new enhancements deliver solutions for studying RNA that provide rapid turn-around time, broad study flexibility and sequencing scalability while delivering exceptional data quality for infectious disease, oncology, and […]
Advanced AI-discovery platform Imagia EVIDENS™ to link analysis of genomic data to patient outcomes for reproducible data-driven precision medicine research MONTRÉAL – Imagia, a leading healthcare AI company that unites healthcare expertise and advanced artificial intelligence technology, and Illumina, a global leader in DNA sequencing and analysis, today announced a partnership to investigate how genomics, clinical data and imaging will […]
Company launches Q Line sequencing portfolio for users in regulated settings Oxford Nanopore today announced its pathway towards providing products for the diagnostics and other regulated markets. Products for customers in regulated environments Q line, launched today, is designed to support users who wish to develop tests based on nanopore sequencing, for deployment in their own environments. The ISO9001-qualified Q […]
Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Pan B-Cell Lymphoma Panel, which is expected to be commercially available for purchase in kit […]
MGI respects the court’s ruling on Illumina’s request for a preliminary injunction, but we do not agree with this decision and we are evaluating our options including an immediate appeal of this ruling. MGI also looks forward to the final decision on this matter after a full trial on the merits has occurred. In […]
To learn more about Canopy’s data analysis offerings, please browse the Canopy website. St. Louis, MO—Canopy Biosciences, a multi-omic CRO providing NanoString® nCounter® and RNA Seq services to both clinical and research customers, has partnered with Onramp BioInformatics™ to offer their ROSALIND™ interactive data analysis platform for Canopy’s gene expression services. Launched earlier this year, Canopy […]
The team that created STRmix™ – sophisticated forensic software used to resolve mixed DNA profiles previously thought to be too complex to interpret – is launching FaSTR™ DNA, expert forensic software that rapidly analyzes DNA profiles and assigns a Number of Contributors (NoC) estimate. Designed by scientists for scientists, FaSTR™ DNA expedites the analysis of […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
